Single-use Bioreactors Market Estimates Industry Size, Share, Trends And Future Growth Study Analysis By 2019-2025

The global single-use bioreactors market is anticipated to show decent growth as it rides on the development of the biotechnology industry and increasing demand in the biotechnology manufacturing sector. The disposable nature of single-use bioreactors as well as their flexibility and simplicity create lucrative market opportunities in laboratory and commercial applications. Since the use of single-use bioreactors does not involve costly and extensive sterilization and cleaning procedures, they are largely adopted for fast-track bioprocessing, biopharmaceutical manufacturing, and biotechnology projects.

Manufacturers are predicted to form strategic agreements with other companies to develop new technologies and products. In March 2019, ARTeSYN Biosolutions and Pall Corporation expanded their collaboration agreement for accelerating single-use technology industrialization.

Low Complexity and Environmental Impact of Single-use Bioreactors to Increase Adoption

Key factors such as low automation complexity of single-use bioreactors and their growing uptake among startups and small organizations are expected to boost product demand. Single-use bioreactors are disposable, which helps end users to cut down on maintenance, cleaning, and sterilization costs when using them. There are several other advantages that single-use bioreactors offer to end users: low environmental impact and easy cultivation of marine organisms.

Get PDF template of this report: https://www.qyrconsulting.com/request-sample/7341

Companies to Introduce New and Innovative Offerings to Gain High Share of Global Market

The report covers key players of the global single-use bioreactors market, including GE Healthcare, Merck Group, Infors AG, Danaher Corporation, Cell-tainer Biotech B.V., Sartorius AG, Parker-Hannifin Corporation, Thermo Fisher Scientific Inc., Distek, Inc., Eppendorf AG, Pierre Guerin Technologies, Applikon Biotechnology B.V., PBS Biotech, Inc., Solaris Biotechnology SRL, CESCO Bioengineering Co., Ltd., and Cellexus Ltd. In order to maintain their market growth, players are foretold to focus on expansion, new product launch, and collaboration, acquisition, and merger agreements in the coming years.

Sartorius Stedim Biotech, a subsidiary of German pharmaceutical and laboratory equipment supplier Sartorius, introduced a new single-use vessel for its benchtop automated mini bioreactor system ambr 250 modular in June 2019. The new vessel finds use in gene and cell therapy applications.

By Product

● Single-use Bioreactors

● Media Bags

● Filtration Assemblies

● Others

By Type

● Stirred Tank

● Wave-induced

● Bubble-column

● Others

By Cell Type

● Mammalian

● Bacterial

● Yeast

Among products, single-use bioreactors are foreseen to take hold of a substantial market share because of their increased adoption in the biopharmaceutical industry. There are various advantages associated with the use of single-use bioreactors, which include low risk of cross-contamination and quick turnaround time. Among cell types, mammalian is projected to gain significant growth in the global single-use bioreactors market. Mammalian cells are widely used in the biologics manufacturing sector because of their remarkable therapeutic efficiency.

Get Complete Report in your Inbox within 24 hours: https://www.qyrconsulting.com/checkout/7341

Contact US
QYR Consulting
17890 Castleton, Suite 218,
Los Angeles, CA – 91748
USA: +1 626 428 8800
China: +86 1082 945 717
Japan: +81 9038 009 273
India: +91 9766 478 224
Emails – sales@qyrconsulting.com
Web – https://www.qyrconsulting.com

About Us:
QYR Consulting established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.

This release was published on openPR.